Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
NCT01436500
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatorenal Syndrome
Interventions
DRUG:
Ifetroban Injection
DRUG:
Placebo
Sponsor
Cumberland Pharmaceuticals